Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease gastroesophageal reflux disease
Phenotype C0039446|telangiectasias
Sentences 1
PubMedID- 23492605 Methods: the treatment regimen provides for initial treatment of type a telangiectasias with just conventional reflux sclerotherapy, followed three weeks later by treatment of type b telangiectasias with 0.25-0.5% polidocanol foam, associated with both external compression and tumescent vasoconstriction (start technique).

Page: 1